The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AMLSabine Käyser, Konstanze Döhner, Jürgen Krauter et al.|Blood|2010Cited by 485
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)Benjamin Hanfstein, Gudrun Göhring, Ulrike Proetel et al.|Leukemia|2012Cited by 417
Monitoring of Minimal Residual Disease in <i>NPM1</i> -Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study GroupJan Krönke, Konstanze Döhner, Richard F. Schlenk et al.|Journal of Clinical Oncology|2011Cited by 393
Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IVAlice Fabarius, Armin Leitner, Andreas Hochhaus et al.|Blood|2011Cited by 289
Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategiesSabine Käyser, Manuela Zucknick, Konstanze Döhner et al.|Blood|2011Cited by 151